Literature DB >> 20800631

Oligoarginine-linked polymers as a new class of penetration enhancers.

Shinji Sakuma1, Masaya Suita, Yoshie Masaoka, Makoto Kataoka, Noriko Nakajima, Norihiro Shinkai, Hitoshi Yamauchi, Ken-ichiro Hiwatari, Hiroyuki Tachikawa, Ryoji Kimura, Shinji Yamashita.   

Abstract

Oligoarginines, which are known as cell-penetrating peptides, enhance the cellular uptake of poorly membrane-permeable bioactive molecules that are chemically conjugated to them. We designed a novel polymer: oligoarginine-linked poly(N-vinylacetamide-co-acrylic acid), with the expectation that the polymers will enhance the cellular uptake of the bioactive molecules that are physically mixed with them. Oligoarginines were grafted onto the polymer backbone through the chemical reaction with acrylic acid functional groups. The changes in the blood glucose concentration after nasal administration of insulin with and without the polymer were monitored in mice. The blood glucose concentration was slightly reduced when insulin was given solely at a dose of 10IU/kg. A D-octaarginine-linked poly(N-vinylacetamide-co-acrylic acid) with a grafting degree of 2% significantly enhanced the insulin-induced hypoglycemic effect. A similar enhancement was not observed when the polymer was substituted with intact D-octaarginine. The penetration-enhancing function of D-octaarginine-linked poly(N-vinylacetamide-co-acrylic acid) increased dramatically with an increase in the grafting degree of D-octaarginine. Substitution of D-octaarginine with the corresponding optical isomer and an increase in the number of arginine residues rather reduced the penetration-enhancing function. In vitro cell studies also indicated that a D-octaarginine-linked poly(N-vinylacetamide-co-acrylic acid) with a grafting degree of 17% enabled fluorescein isothiocyanate-dextran to effectively penetrate the cell membrane. Results demonstrated that our oligoarginine-linked polymer has a potential to provide a new class of penetration enhancers.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800631     DOI: 10.1016/j.jconrel.2010.08.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

Review 2.  Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.

Authors:  Hua Li; Tung Yu Tsui; Wenxue Ma
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

3.  Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin.

Authors:  Hae-Duck Bae; Joohyun Lee; Kyu-Yeon Jun; Youngjoo Kwon; Kyunglim Lee
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

4.  Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer's disease.

Authors:  Francisco Morales-Zavala; Nathalie Casanova-Morales; Raúl B Gonzalez; América Chandía-Cristi; Lisbell D Estrada; Ignacio Alvizú; Victor Waselowski; Fanny Guzman; Simón Guerrero; Marisol Oyarzún-Olave; Cristian Rebolledo; Enrique Rodriguez; Julien Armijo; Heman Bhuyan; Mario Favre; Alejandra R Alvarez; Marcelo J Kogan; Jerónimo R Maze
Journal:  J Nanobiotechnology       Date:  2018-08-10       Impact factor: 10.435

5.  Evaluation of a D-Octaarginine-linked polymer as a transfection tool for transient and stable transgene expression in human and murine cell lines.

Authors:  Saki Sakuma; Mariko Okamoto; Nao Matsushita; Masami Ukawa; Takumi Tomono; Keiko Kawamoto; Teruo Ikeda; Shinji Sakuma
Journal:  J Vet Med Sci       Date:  2022-02-08       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.